Search results for " Type A"

showing 7 items of 67 documents

Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A…

2006

Laboratory diagnosis of lysosomal storage disorders, especially sphingomyelinase deficiency (Niemann–Pick disease type A/B) and Niemann–Pick disease type C (NPC) can be challenging. We therefore aimed to analyse the feasibility of first-step screening with specific chitotriosidase cut-off values in children ≤ 10 years of age with visceral organomegaly (hepatomegaly, splenomegaly, or hepatosplenomegaly) in whom a storage disorder was suspected. We conducted a retrospective, cross-sectional, referral, single-centre study to assess diagnostic test properties in 106 individuals. Median chitotriosidase activity was 12 655 nmol/h per ml (interquartile range 4693–20982) in Gaucher disease (GD); 78…

medicine.medical_specialtyHepatosplenomegalyGastroenterologySensitivity and SpecificityOrganomegalyCentral nervous system diseaseDiagnosis DifferentialInterquartile rangePredictive Value of TestsInternal medicineGene DuplicationGenotypeGeneticsMedicineGlycogen storage diseaseHumansChildGenetics (clinical)Retrospective StudiesGaucher Diseasebusiness.industryInfantNiemann-Pick Disease Type CNiemann-Pick Disease Type BNiemann-Pick Disease Type Amedicine.diseaseEndocrinologyHexosaminidasesChemistry ClinicalChild Preschoolmedicine.symptomDifferential diagnosisbusinessNiemann–Pick diseaseJournal of inherited metabolic disease
researchProduct

Oral health effects of botulinum toxin treatment for drooling:a systematic review

2020

Background Drooling is a major morbidity in several neurological diseases. Intraglandular botulinum neurotoxin (BoNT) injections have been used to manage this condition. However, by decreasing salivary flow, BoNT injections may result in an increased risk of caries and other oral adverse effects. In this study, we aimed to assess whether, in patients with drooling, intraglandular BoNT injections are associated with increased dental caries development, modifications on salivary composition (oral pH, buffering capacity and osmolality) and cariogenic bacterial load. Material and Methods We performed a systematic review, searching PubMed, CENTRAL, Web of Science, and Scopus for all experimental…

medicine.medical_specialtyMEDLINEOral HealthReviewOral healthDental CariesDroolinglaw.inventionameloblastomaRandomized controlled triallawInternal medicinemedicineHumansBotulinum Toxins Type AAdverse effectGeneral DentistryUNESCO:CIENCIAS MÉDICASbusiness.industryCerebral Palsyodontogenic tumorSialorrheaMedically compromised patients in Dentistryameloblastoma recurrenceBotulinum toxinOtorhinolaryngologyNeuromuscular AgentsSurgeryObservational studymedicine.symptombusinessoral pathologyBiomedical sciencesmedicine.drug
researchProduct

Therapeutic considerations in cerebellopontine angle lipomas inducing hemifacial spasm.

2000

Lipoma is a very rare tumour at the cerebellopontine angle. We report a case of incomplete hemifacial spasm, associated with a lipoma involving and compressing both facial and acoustic nerves at their origin in the brainstem. The patient was treated with medical therapy (botulinum toxin A) and surgery. We present a review of the last ten years of the literature, with particular regard to management.

medicine.medical_specialtyNeurologyDermatologyCerebellopontine Angleotorhinolaryngologic diseasesMedicineHumansHemifacial SpasmBotulinum Toxins Type ACerebellar NeoplasmsNeuroradiologymedicine.diagnostic_testbusiness.industryMagnetic resonance imagingGeneral MedicineLipomaMiddle Agedmedicine.diseaseCerebellopontine angleBotulinum toxinMagnetic Resonance ImagingSurgerybody regionsstomatognathic diseasesPsychiatry and Mental healthTreatment OutcomeNeuromuscular AgentsFemaleNeurology (clinical)NeurosurgeryLipomabusinessmedicine.drugHemifacial spasmNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
researchProduct

A low threshold to ECG-gated repeat CTA reduces the risk of false-positive diagnosis of type A dissection in interhospital referrals: a case series s…

2018

Angela Kornberger,1 Iris Burck,2 Hazem El Beyrouti,1 Nancy Halloum,1 Andres Beiras-Fernandez,1 Christian-Friedrich Vahl1 1Department of Cardiothoracic and Vascular Surgery, University Hospital of Johannes Gutenberg University, Mainz, Germany; 2Department of Diagnostic and Interventional Radiology, University Hospital of Johann Wolfgang Goethe University, Frankfurt am Main, Germany Background: False-positive diagnosis of acute Stanford type A aortic dissection (AAD) on computed tomography angiography (CTA) is still an issue and may lead to substantial consequences. Given that electrocardiography (ECG)-gated CTA provides greater diagnostic safety, it may be assumed that interhospital referral…

medicine.medical_specialtyStanford type A dissectionTherapeutics and Clinical Risk Managementfalse-positive diagnosisECG-gated CTA030204 cardiovascular system & hematology030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicinePharmacology (medical)Case Seriescardiovascular diseasesGeneral Pharmacology Toxicology and PharmaceuticsType a dissectionComputed tomography angiographyAortic dissectionChemical Health and Safetymedicine.diagnostic_testbusiness.industrymusculoskeletal neural and ocular physiologyGeneral Medicinemedicine.diseaseRadiologybusinessSafety ResearchElectrocardiographypsychological phenomena and processesCase seriesTherapeutics and Clinical Risk Management
researchProduct

Efficacy of botulinum toxin in the treatment of bruxism : systematic review

2019

Background Currently it has been shown that botulinum toxin is effective for a wide variety of medical conditions, and can be applied for therapeutic purposes as cosmetic. In recent years, there has been a growing trend in the use of this drug substance to control the muscular overactivity of bruxism. The objective of this study was the use of botulinum toxin type A (BTX-A) than traditional methods, by conducting a systematic review of randomized clinical trials (RCTs) published in the health sciences literature. Material and Methods An electronic search was made in the databases of the PubMed, Cochrane Library and Scopus data between March and October 2017, ECA, which will analyze the effe…

medicine.medical_specialtyToxina botulínicaMEDLINEReviewCochrane LibraryPlaceboInjections Intramuscularlaw.inventionMasseter muscleOcclusal Splints03 medical and health sciences0302 clinical medicineRandomized controlled triallawBotulinum toxinmedicineHumansBotulinum Toxins Type AGeneral DentistryOral Medicine and Pathologybusiness.industryMasseter MuscleBruxisme030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Botulinum toxinstomatognathic diseasesOtorhinolaryngologyNeuromuscular AgentsUNESCO::CIENCIAS MÉDICASPhysical therapySurgeryBruxismbusinessBiomedical sciencesmedicine.drug
researchProduct

Optic neuropathy caused by type A botulinic toxin

2014

Purpose To report the development of an optical neuropathy after injection of type A botulinic toxin in a subject with blepharospasm. Methods Optical neuropathy was evaluated through a complete ophthalmologic examination consisting of bio-microscopy, tonometry and study of visual sharpness, colour test, visual field, OCT, fluorangiography and determination of VEPs. Results Intravenous therapy was begun with Metilprednisolone (20 mg/Kg/day) and Vitamin B6 associated with oral Citicoline, and there was a clear improvement down to normalization of the symptoms. After 6 months the Humphrey computerized visual field with central 30-2 program threshold test emphasised in ODx an upper half-field a…

medicine.medical_specialtygenetic structuresmedicine.diagnostic_testbusiness.industryThreshold testSettore MED/30 - Malattie Apparato VisivoBlepharospasmGeneral MedicineBlepharospasm Type A botulinic toxin Optic neuropathymedicine.diseaseeye diseasesSurgeryVisual fieldOptic neuropathyMajor duodenal papillaPerimeterOphthalmologyOptical coherence tomographyOphthalmologyFixation (visual)medicineType A botulinic toxinsense organsmedicine.symptombusiness
researchProduct

Botulinum Toxin A for Oral Cavity Cancer Patients: In Microsurgical Patients BTX Injections in Major Salivary Glands Temporarily Reduce Salivary Prod…

2012

Abstract: In patients suffering from oral cavity cancer surgical treatment is complex because it is necessary to remove carcinoma and lymph node metastasis (through a radical unilateral or bilateral neck dissection) and to reconstruct the affected area by means of free flaps. The saliva stagnation in the post-operative period is a risk factor with regard to local complications. Minor complications related to saliva stagnation (such as tissue maceration and wound dehiscence) could become major complications compromising the surgery or the reconstructive outcome. In fact the formation of oro-cutaneous fistula may cause infection, failure of the free flap, or the patient’s death with carotid b…

oro-cutaneous fistulaMicrosurgerysaliva-related complicationsmedicine.medical_specialtySalivaHealth Toxicology and Mutagenesismedicine.medical_treatmentSettore MED/19 - Chirurgia Plasticalcsh:MedicineFree flapToxicologySalivary GlandsSurgical FlapsArticleforearm free flapPostoperative ComplicationsBotulinum toxinMajor Salivary GlandmedicineHumansBotulinum Toxins Type ARadionuclide ImagingSalivaBotulinum toxin; salivary production; oral cancer; free flap complications; saliva-related complications; forearm free flap; oro-cutaneous fistula; salivary major glandsfree flap complicationsMouth neoplasmWound dehiscencebusiness.industryBotulinum toxin salivary production oral cancer free flap complications saliva-related complications forearm free flap oro-cutaneous fistula salivary major glandslcsh:RNeck dissectionSialorrheaPlastic Surgery Proceduresoral cancerMicrosurgerymedicine.diseaseBotulinum toxinsalivary productionSurgeryTreatment Outcomesalivary major glandsMouth Neoplasmsbusinessmedicine.drugToxins
researchProduct